Latest News & Features
Americas
UK-based medical technologies manufacturer Hill-Rom has sued General Electric (GE), claiming that the company infringes three patents covering hygiene monitoring systems. 9 May 2014
Americas
Acura Pharmaceuticals and Ranbaxy have agreed to settle their patent infringement litigation related to painkiller Aversion (oxycodone hydrochloride), once marketed by Pfizer under its registered trademark Oxecta. 8 May 2014
Americas
The US Federal Trade Commission (FTC) has filed an amicus brief in an antitrust case that concerns a “no-authorised-generic” settlement between Teva and GlaxoSmithKline (GSK). 7 May 2014
article
Allergan, along with Japan-based Senju and Kyorin have sued Indian pharma Aurobindo for infringing claims in the Japanese pharmaceutical companies’ reexamined US patent 6,333,045. 6 May 2014
Americas
Bayer AG has agreed to buy New Jersey-based Merck’s consumer care business for $14.2 billion, the companies announced today (May 6). 6 May 2014
Americas
Cephalon has filed another lawsuit to protect its chronic lymphocytic leukaemia and non-Hodgkin’s lymphoma treatment Treanda (bendamustine hydrochloride), this time against Canadian pharmaceutical company Uman Pharma. 1 May 2014
Europe
HGF has promoted Mike Nelson to partner. He joined the firm last year to work with the pharmaceutical and chemistry teams after arriving from AstraZeneca. 1 May 2014
Asia
Patent protection in the pharmaceutical sector in India has raised “serious” concerns, the US government said yesterday, April 30, in its annual Special 301 Report. 1 May 2014
Asia
Arguments over the term of the patents granted are at the heart of the Copaxone conflict, says Archana Shanker. 30 April 2014
Europe
Horizon Discovery’s cell line-creating technology has the potential to advance personalised medicine. But how does the gene editing company stay
competitive in a crowded field? LSIPR found out. 30 April 2014